This story has been updated with information from the company's earnings call.
NEW YORK --NeoGenomics reported Tuesday that its first quarter revenues grew 11 percent year over year with clinical service revenues up 8 percent.
For the three months ended March 31, the Fort Myers, Florida-based company recorded revenues of $106 million compared to $95.6 million a year ago. It beat the consensus Wall Street estimate of $104.6 million.